(RTTNews) - Samsung Bioepis Co., Ltd. and Biogen Inc. (BIIB) Monday announced that the European Commission (EC) has approved Opuviz, a biosimilar to Regeneron Pharmaceuticals' Aflibercept.
And most recently, new research suggests that people who eat more UPFs are at increased risk of type 2 diabetes, with the UCL Division of Medicine study showing ... was a large three chicken select ...